Larvol Delta - EMA-Grants-Orphan-Medicinal-Product-Designation-for-Retrotopes-RT001-in-the-Treatment-of-Infantile-Neuroaxonal-Dystrophy-INAD-a-PLA2G6-associated-neurodegeneration-PLAN

botulinum neurotoxin type A gel formulation (RT001) - Revance

RT001 - Retrotope

http://www.globenewswire.com/news-release/2019/03/13/1752718/0/en/EMA-Grants-Orphan-Medicinal-Product-Designation-for-Retrotope-s-RT001-in-the-Treatment-of-Infantile-Neuroaxonal-Dystrophy-INAD-a-PLA2G6-associated-neurodegeneration-PLAN.html

Mar 13, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev